{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T16:58:20Z","timestamp":1778691500831,"version":"3.51.4"},"reference-count":48,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1820,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1111\/j.1399-3046.2010.01389.x","type":"journal-article","created":{"date-parts":[[2010,9,8]],"date-time":"2010-09-08T00:13:01Z","timestamp":1283904781000},"page":"986-992","source":"Crossref","is-referenced-by-count":13,"title":["Increased pretransplant QT dispersion as a risk factor for the development of cardiac complications during and after preparative conditioning for pediatric allogeneic hematopoietic stem cell transplantation"],"prefix":"10.1111","volume":"14","author":[{"given":"Noriko","family":"Motoki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Akazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyuki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryu","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohiko","family":"Motoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yozo","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Sakashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Shiohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Koike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,9,7]]},"reference":[{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1470-2045(01)00516-2","article-title":"Childhood acute lymphoblastic leukemia: Current status and future perspectives","volume":"2","author":"Pui","year":"2001","journal-title":"Lancet Oncol"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM199808273390907","article-title":"Acute lymphoblastic leukemia","volume":"339","author":"Pui","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/pbc.20944","article-title":"Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: Long-term outcome of the children with AML treated on two consecutive trials of Tokyo children\u2019s cancer study group","volume":"49","author":"Tomizawa","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1111\/j.1540-8159.1996.tb03246.x","article-title":"Clinical significance of increased OT dispersion in the 12-lead standard ECG for arrhythmia risk prediction in dilated cardiomyopathy","volume":"19","author":"Grimm","year":"1996","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/clc.4960151010","article-title":"QT-interval abnormalities in hypertrophic cardiomyopathy","volume":"15","author":"Dritsas","year":"1992","journal-title":"Clin Cardiol"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0002-9149(96)00756-4","article-title":"Enalapril reduces QTc dispersion in mild congestion heart failure secondary to coronary artery disease","volume":"79","author":"Barr","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/BF02766801","article-title":"Ventricular repolarization time indexes following anthracycline treatment","volume":"12","author":"Sarubbi","year":"1997","journal-title":"Heart Vessels"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1046\/j.1365-2796.1999.00480.x","article-title":"QT dispersion and late potentials during doxorubicin therapy for non-Hodgkin\u2019s lymphoma","volume":"245","author":"Nousiainen","year":"1999","journal-title":"J Intern Med"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB9|cit9","first-page":"1047","article-title":"Prolonged corrected QT dispersion: Early sign of doxorubicin cardiotoxicity?","volume":"4","author":"Orditura","year":"1997","journal-title":"Oncol Rep"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB10|cit10","first-page":"107","article-title":"Cardiac functions by myocardial performance index and QT dispersion in survivors of childhood lymphoblastic leukemia","volume":"59","author":"Gulen","year":"2007","journal-title":"Minerva Pediatr"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1080\/08880010290097387","article-title":"Presence of prolonged dispersion of QT intervals in late survivors of childhood","volume":"19","author":"Gupta","year":"2002","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajh.20042","article-title":"Predictive value of QT dispersion for acute heart failure after autologous and allogeneic hematopoietic stem cell transplantation","volume":"76","author":"Nakamae","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1161\/01.CIR.98.18.1928","article-title":"Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome","volume":"98","author":"Yan","year":"1998","journal-title":"Circulation"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0002-8703(98)70119-X","article-title":"Regression of left ventricular hypertrophy results in improvement of QT dispersion in patients with hypertension","volume":"136","author":"Kapanou","year":"1998","journal-title":"Am Heart J"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB15|cit15","first-page":"353","article-title":"An analysis of the time-relations of electrocardiograms","volume":"7","author":"Bazett","year":"1920","journal-title":"Heart"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/01.CIR.98.20.2160","article-title":"Influence of lead selection of population on automated measurement of QT dispersion","volume":"98","author":"Macfarlane","year":"1998","journal-title":"Circulation"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/0002-9149(94)90462-6","article-title":"Variability of QT dispersion measurements in the surface electrocardiogram in patients with acute myocardial infarction and in normal subjects","volume":"74","author":"Van De Loo","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1540-8167.1996.tb00583.x","article-title":"Will QT dispersion play a role in clinical decision-making?","volume":"7","author":"Surawics","year":"1996","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJM197112232852601","article-title":"The natural history of congestive heart failure: The Framingham study","volume":"285","author":"Mckee","year":"1971","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/0959-8049(92)90066-B","article-title":"Early assessment of a new anticancer drug analogue-are the historical comparisons obsolete - the French experience with pirarubicin","volume":"28A","author":"Herait","year":"1992","journal-title":"Eur J Cancer"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB21|cit21","first-page":"16","article-title":"Antileukemic activity and cardiac toxicity of 4-demethoxydaunorubicin (4-DMD) in mice","volume":"20","author":"Casazza","year":"1979","journal-title":"Proc Am Assoc Cancer Res"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/hrt.81.6.650","article-title":"Accuracy of electrocardiographic indicesin predicting life threatening ventricular arrhythmias in patients operated for tetralogy of Fallot","volume":"81","author":"Dalient","year":"1999","journal-title":"Heart"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3346\/jkms.2004.19.5.652","article-title":"The usefulness of surface electrocardiogram as a prognostic predictor in children with idiopathic dilated cardiomyopathy","volume":"19","author":"Huh","year":"2004","journal-title":"J Korean Med Sci"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0735-1097(98)00493-8","article-title":"Long-term outcome and prognostic determinants in children with hypertrophic cardiomyopathy","volume":"32","author":"Yetman","year":"1998","journal-title":"JACC"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s00246-003-0478-3","article-title":"Repolarization abnormalities in children with a structurally normal heart and ventricular Ectopy","volume":"25","author":"Das","year":"2004","journal-title":"Pediatr Cardiol"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0735-1097(00)00962-1","article-title":"Measurement, interpretation and clinical potential of QT dispersion","volume":"36","author":"Malik","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1002\/1097-0142(19860515)57:10<2061::AID-CNCR2820571031>3.0.CO;2-H","article-title":"Cardiac complications after bone marrow transplantation. A report on a series of 63 consecutive transplantations","volume":"57","author":"Cazin","year":"1986","journal-title":"Cancer"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/mpo.2950090502","article-title":"Cardiac changes with cyclophosphamide","volume":"9","author":"Steinherz","year":"1981","journal-title":"Med Pediatr Oncol"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/sj.bmt.1702466","article-title":"Cardiac systolic function before and after hematopoietic stem cell transplantation","volume":"26","author":"Lehmann","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1182\/blood.V68.5.1114.1114","article-title":"Cyclophosphamide cardiotoxicity: An analysis of dosing as a risk factor","volume":"68","author":"Goldberg","year":"1986","journal-title":"Blood"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/sj.bmt.1702234","article-title":"Cardiac and pulmonary toxicity in patients undergoing high-dose chemotherapy for lymphoma and breast cancer: Prognostic factors","volume":"25","author":"Brockstein","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB32|cit32","first-page":"173","article-title":"Radionuclide ejection fractions in the evaluation of patients being considered for bone marrow transplantation: Risk for cardiac toxicity","volume":"5","author":"Bearman","year":"1990","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB33|cit33","first-page":"998","article-title":"Cardiac toxicity of bone marrow transplantation: Predictive value of cardiologic evaluation before transplant","volume":"12","author":"Hertstein","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/sj.bmt.1702783","article-title":"Severe cardiac toxicity in hematopoietic stem cell transplantation: Predictive value of reduced left ventricular ejection fraction","volume":"27","author":"Fujimaki","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB35|cit35","first-page":"873","article-title":"Clinical spectrum of anthracycline cardiotoxicity","volume":"12","author":"Bristow","year":"1978","journal-title":"Cancer Treat Rep"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2","article-title":"A clinicopathologic analysis of adriamycin cardiotoxicity","volume":"33","author":"Lefrak","year":"1973","journal-title":"Cancer"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/0002-9343(87)90212-9","article-title":"Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiography","volume":"82","author":"Schwartz","year":"1987","journal-title":"Am J Med"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/1097-0142(19850615)55:12<2761::AID-CNCR2820551206>3.0.CO;2-P","article-title":"Early and delayed clinical cardiotoxity of doxorubicin","volume":"55","author":"Buzdar","year":"1985","journal-title":"Cancer"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/pbc.21105","article-title":"Longitudinal evaluation of early and late anthracycline cardiotoxicity in children with AML","volume":"48","author":"Creuzig","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1200\/JCO.1998.16.2.545","article-title":"Relationship between cumulative anthracycline dose and late cardiotoxity in childhood acute lymphoblastic leukemia","volume":"16","author":"Nysom","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1200\/JCO.1993.11.10.1906","article-title":"Corrected QT interval prolongation in anthracycline-treated survivors of childfood cancer","volume":"11","author":"Schwartz","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1096\/fasebj.4.13.2210154","article-title":"Doxorubicin cardiotoxicity: Analysis of prevailing hypotheses","volume":"4","author":"Olson","year":"1990","journal-title":"FASEB J"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1172\/JCI117833","article-title":"Secondary alcohol metabolites mediate iron delocalization in cytosolic fractions of myocardial biopsies exposed to anticancer anthracyclines. Novel linkage between anthracycline metabolism and iron-induced cardiotoxicity","volume":"4","author":"Minotti","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0140-6736(00)02051-1","article-title":"QT dispersion as a predictor of acute heart failure after high-dose cyclophosphamide","volume":"355","author":"Nakamae","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB45|cit45","first-page":"573","article-title":"Fetal cyclophosphamide cardiomyopathy: Its clinical course and treatment","volume":"18","author":"Lee","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"30G","DOI":"10.1016\/S0002-9149(00)00988-7","article-title":"Assessment of regional left ventricular function during exercise test with pulsed tissue Doppler imaging","volume":"86","author":"Dagianti","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB47|cit47","first-page":"135","article-title":"New non-invasive index for combined systolic and diastolic ventricular function","volume":"26","author":"Tei","year":"1995","journal-title":"J Cardiol"},{"key":"10.1111\/j.1399-3046.2010.01389.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/j.1540-8175.2009.00920.x","article-title":"Tei index correlates with tissue Doppler parameters and reflects neurohormonal activation in patients with an abnormal transmitral flow pattern","volume":"26","author":"Greco","year":"2009","journal-title":"Echocardiography"}],"container-title":["Pediatric Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-3046.2010.01389.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1399-3046.2010.01389.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T01:26:51Z","timestamp":1625621211000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-3046.2010.01389.x"}},"subtitle":["Pretransplant QTD for cardiac complications"],"short-title":[],"issued":{"date-parts":[[2010,9,7]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,12]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1399-3046.2010.01389.x","relation":{},"ISSN":["1397-3142"],"issn-type":[{"value":"1397-3142","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9,7]]}}}